tradingkey.logo
搜尋

Enovis Corp

ENOV
添加自選
21.700USD
+1.660+8.28%
收盤 07/02, 13:00美東報價延遲15分鐘
1.25B總市值
虧損本益比TTM

Enovis Corp

21.700
+1.660+8.28%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

+8.28%

5天

+1.50%

1月

0.00%

6月

-18.54%

今年開始到現在

-18.54%

1年

-34.28%

關鍵數據
20.610今開
21.750最高
457.15K成交量
虧損本益比TTM
5.22本益比動
--股利TTM
0.79%換手率
20.040昨收
20.230最低
5.96M成交額
虧損本益比靜
0.85市淨率
0.00%股息率 TTM
-26.06%ROA
38.19052週最高
0.55量比
-825.49M淨利潤
57.55M總股本
-19.9221每股盈餘TTM
1.23Beta
-55.46%ROE
21.00052週最低
7.58%振幅
54.92%毛利率
1.25B總市值
-2.68回報/風險
3.23%風險率

TradingKey Enovis Corp股票評分

單位: USD 更新時間: 2026-07-01

操作建議

Enovis Corp當前公司基本面數據相對穩定,增長潛力很大。當前估值合理,在醫療設備與耗材行業排名65/204位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為42.30。中期看,股價處於下降通道。近一個月,市場表現較差,但公司基本面和技術面得分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Enovis Corp評分

相關信息

行業排名
65 / 204
全市場排名
177 / 4564
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

Enovis Corp亮點

亮點風險
Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
業績高增長
公司營業收入穩步增長,連續3年增長31.68%
利潤高增長
公司淨利潤處於行業前列,最新年度總收入2.25B美元
估值高估
公司最新PE估值-1.01,處於3年歷史高位
機構減倉
最新機構持股68.97M股,環比減少8.93%
梅森·霍金斯持倉
明星投資者梅森·霍金斯持倉,最新持倉43.70K股

分析師目標

基於 11 分析師
買入
評級
42.300
目標均價
+104.35%
漲幅空間

Enovis Corp新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Enovis Corp簡介

Enovis Corporation is a medical technology company. It is focused on developing clinically differentiated solutions by manufacturing and distributing high-quality medical devices with a range of products used for reconstructive surgery, rehabilitation, pain management and physical therapy. It operates through two segments: Prevention & Recovery and Reconstructive. The Prevention & Recovery segment provides orthopedic and recovery science solutions, including devices, software, and services across the patient care continuum from injury prevention to rehabilitation after surgery, injury, or from degenerative diseases. The Prevention & Recovery products are marketed under several brand names, such as DJO. The Reconstructive segment provides surgical implant solutions, offering a comprehensive suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger and surgical productivity tools. It also operates a Enovis Growth eXcellence business system (EGX).
公司代碼ENOV
公司Enovis Corp
CEOMcdonald (Damien)
網址https://www.enovis.com/

常見問題

Enovis Corp(ENOV)的當前股價是多少?

Enovis Corp(ENOV)的當前股價是 20.03。

Enovis Corp 的股票代碼是什麼?

Enovis Corp的股票代碼是ENOV。

Enovis Corp股票的52週最高點是多少?

Enovis Corp股票的52週最高點是38.19。

Enovis Corp股票的52週最低點是多少?

Enovis Corp股票的52週最低點是21.00。

Enovis Corp的市值是多少?

Enovis Corp的市值是1.15B。

現在Enovis Corp(ENOV)的股票是買入、持有還是賣出?

根據分析師評級,Enovis Corp(ENOV)的總體評級為買入,目標價格為42.30。

Enovis Corp(ENOV)股票的每股收益(EPS TTM)是多少

Enovis Corp(ENOV)股票的每股收益(EPS TTM)是-20.75。